1. CD69 partially inhibits apoptosis and erythroid differentiation via CD24, and their knockdown increase imatinib sensitivity in BCR‐ABL‐positive cells
   Shih‐Yun Huang et al, 2018, Journal of Cellular Physiology CrossRef
2. Impact of Methimazole Treatment on Magnesium Concentration and Lymphocytes Activation in Adolescents with Graves’ Disease
   Maria Klatka et al, 2013, Biological Trace Element Research CrossRef
3. NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms
   Li Yu et al, 2017, Blood Reviews CrossRef
4. B cell activation and proliferation increase intracellular zinc levels
   Johanna Ollig et al, 2019, The Journal of Nutritional Biochemistry CrossRef
5. Activin A downregulates the CD69-MT2A axis via p38MAPK to induce erythroid differentiation that sensitizes BCR-ABL-positive cells to imatinib
   Chih-Wei Chen et al, 2022, Experimental Cell Research CrossRef